Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kathleen Lee

Physician Assistant, Medical Sarasota, FL Physician Assistant

NPI 1336737501 CMS profile 10916909

600 N Cattlemen Rd Ste 200, Sarasota, FL 34232

Open in the dashboard

General payments

$10,440

458 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kathleen Lee of Sarasota, FL is reported in the CMS Open Payments database as having received $10,440 across 458 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,115 94
2024 General $2,460 110
2023 General $3,101 109
2022 General $1,878 92
2021 General $886 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kathleen Lee
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Kathleen Lee were reported at $2,115. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Kathleen Lee Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $886 $156 $41–$563 $132
2022 $1,878 $185 $55–$649 $149
2023 $3,101 $199 $58–$717 $160
2024 $2,460 $206 $62–$740 $164
2025 $2,115 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Exelixis Inc. $1,009 1 payment
  2. Novartis Pharmaceuticals Corporation $718 43 payments
  3. Celgene Corporation $680 26 payments
  4. Merck Sharp & Dohme Corporation $674 30 payments
  5. E.R. Squibb & Sons, L.L.C. $662 39 payments
  6. Daiichi Sankyo Inc. $652 26 payments
  7. Incyte Corporation $528 20 payments
  8. AstraZeneca Pharmaceuticals LP $431 22 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $309 14 payments
  10. Array BioPharma Inc. $267 12 payments
  11. Other $4,511 225 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,340 457 payments
  2. Education $100 1 payment
Products named General payments · program years 2021–2025
  1. CABOMETYX $1,009 1 payment
  2. KEYTRUDA $614 27 payments
  3. ENHERTU $599 23 payments
  4. OPDIVO $500 30 payments
  5. REBLOZYL $491 15 payments
  6. JAKAFI $342 15 payments
  7. IMBRUVICA $327 14 payments
  8. LYNPARZA $303 14 payments
  9. EPKINLY $261 12 payments
  10. BRAFTOVI $246 11 payments
  11. Other $8,228 420 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

458 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record